Vastagbélrák: vizsgálatok itt: Svájc

In Svájc 23 Also abroad 1930

23 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Bern, Geneva, Zurich
Életkor
18 év and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Where
Bern, Lausanne, Sankt Gallen
Életkor
18 év and over
People
700 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07284849 · EU 2025-523735-19-00
1/2. fázisTaking people
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Where
Bellinzona, Geneva
Életkor
18 év and over
People
220 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00
2. fázisTaking people
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Where
Zurich
Életkor
18 év and over
People
140 worldwide
Run by
Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00
1. fázisTaking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Chur, Sankt Gallen, Winterthur
Életkor
18 év and over
People
1394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
2. fázisTaking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Basel, Bellinzona, Sankt Gallen
Életkor
18 év to 130 év
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
No phaseTaking people
Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
Where
Basel, Biel, Lucerne
Életkor
18 év and over
People
234
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07829081
3. fázisTaking people
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Where
Zurich
Életkor
18 év and over
People
450 worldwide
Run by
Amgen
See details and how to joinNCT06252649
1. fázisTaking people
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Where
Geneva, Lausanne
Életkor
18 év to 100 év
People
162 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06562192
No phaseTaking people
Colorectal Resections in Patients With Retroperitoneal Sarcoma
Where
Basel
Életkor
18 év and over
People
120 worldwide
Run by
Heidelberg University
See details and how to joinNCT06943612
3. fázisTaking people
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Where
Schlieren, Zurich
Életkor
18 év and over
People
400 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05253651 · EU 2024-514180-25-00
No phaseTaking people
Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Where
Aarau, Baden, Basel, Bern, Biel, Chur, Lucerne, Sankt Gallen, Solothurn, Villars-sur-Glâne, Winterthur, Zurich
Életkor
18 év and over
People
30
Run by
Swiss Cancer Institute
See details and how to joinNCT07617610
No phaseTaking people
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Where
Lausanne
Életkor
22 év to 70 év
People
250 worldwide
Run by
Colospan Ltd.
See details and how to joinNCT04184973
2. fázisTaking people
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Where
Bern, Geneva
Életkor
18 év and over
People
120 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06567782
3. fázisTaking people
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
Where
Basel, Bern, Lucerne, Winterthur
Életkor
18 év and over
People
140
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT06936774
No phaseTaking people
Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
Where
Bern
Életkor
18 év and over
People
200
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT06249672
No phaseTaking people
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Where
Bern
Életkor
18 év and over
People
200
Run by
University of Bern
See details and how to joinNCT07280143
2. fázisTaking people
Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Where
Bellinzona
Életkor
18 év and over
People
40
Run by
Oncology Institute of Southern Switzerland
See details and how to joinNCT05748145
No phaseTaking people
Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
Where
Geneva
Életkor
18 év and over
People
300 worldwide
Run by
Bordeaux Colorectal Institute Academy
See details and how to joinNCT06154785
No phaseTaking people
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Where
Bern, Zurich
People
302 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06462963
No phaseTaking people
The DRAGON 2 Trial
Where
Basel, Winterthur
Életkor
18 év and over
People
348 worldwide
Run by
Maastricht University
See details and how to joinNCT05428735
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Bern, Zurich
Életkor
18 év and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
2. fázisTaking people
Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Where
Geneva
Életkor
18 év and over
People
25
Run by
University Hospital, Geneva
See details and how to joinNCT04109755